Harnessing Ultrasound for Targeting Drug Delivery to the Brain and Breaching the Blood–Brain Tumour Barrier

Despite significant advances in developing drugs to treat brain tumours, achieving therapeutic concentrations of the drug at the tumour site remains a major challenge due to the presence of the blood–brain barrier (BBB). Several strategies have evolved to enhance brain delivery of chemotherapeutic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Barzegar-Fallah, Anita, Gandhi, Kushan, Rizwan, Shakila B., Slatter, Tania L., Reynolds, John N. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607160/
https://www.ncbi.nlm.nih.gov/pubmed/36297666
http://dx.doi.org/10.3390/pharmaceutics14102231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607160/
https://www.ncbi.nlm.nih.gov/pubmed/36297666
http://dx.doi.org/10.3390/pharmaceutics14102231

Ejemplares similares